Spots Global Cancer Trial Database for hodgkins lymphoma
Every month we try and update this database with for hodgkins lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment | NCT02099266 | Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Hodgkins Lympho... Non-Hodgkins Ly... | Administration ... | 17 Years - 70 Years | University of Kansas Medical Center | |
| 3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma | NCT02057445 | Non-Hodgkins Ly... Hodgkins Lympho... Lymphoprolifera... | EBV CTL's Peripheral Bloo... | 1 Year - | New York Medical College | |
| Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma | NCT01636388 | Hodgkins Lympho... | allogeneic dono... | - 45 Years | New York Medical College | |
| Biology Studies of Hematologic Cancers | NCT00923442 | Acute Lymphobla... Myelodysplastic... Non-Hodgkins Ly... Acute Myelogeno... Hodgkins Lympho... | 1 Year - 75 Years | National Institutes of Health Clinical Center (CC) | ||
| (TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL). | NCT05134740 | Hodgkins Lympho... Non Hodgkins Ly... | TAA-specific CT... | 1 Year - 21 Years | Baylor College of Medicine | |
| TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation | NCT01300611 | Double Cord Blo... Acute Myelogeno... Myelodysplastic... Myelofibrosis Acute Lymphobla... Chronic Myelocy... Non Hodgkins Ly... Hodgkins Lympho... Chronic Lymphoc... | TXA127 300 mcg/... TXA127 1000 mcg... | 18 Years - 60 Years | Tarix Pharmaceuticals | |
| HD18 for Advanced Stages in Hodgkins Lymphoma | NCT00515554 | Hodgkins Lympho... | Rituximab BEACOPP escalat... | 18 Years - 60 Years | University of Cologne | |
| Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma | NCT00383097 | Hodgkins Lympho... Non-Hodgkin Lym... | LMP1 SPECIFIC C... LMP2-SPECIFIC C... | - | Baylor College of Medicine | |
| A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy | NCT00558675 | Hematological M... Leukemia Lymphoma Multiple Myelom... | AlloStim AlloStim AlloStim AlloStim | 18 Years - | Immunovative Therapies, Ltd. | |
| A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma | NCT01712490 | Hodgkin Lymphom... | brentuximab ved... doxorubicin bleomycin vinblastine dacarbazine | 18 Years - | Takeda | |
| TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation | NCT01300611 | Double Cord Blo... Acute Myelogeno... Myelodysplastic... Myelofibrosis Acute Lymphobla... Chronic Myelocy... Non Hodgkins Ly... Hodgkins Lympho... Chronic Lymphoc... | TXA127 300 mcg/... TXA127 1000 mcg... | 18 Years - 60 Years | Tarix Pharmaceuticals | |
| Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning | NCT01572662 | Leukemia Acute Myeloid L... Acute Lymphocyt... Chronic Myeloid... Chronic Lymphoc... Myeloproliferat... Non-Hodgkins Ly... Hodgkins Lympho... Multiple Myelom... Myelodysplastic... | Fludarabine mon... Busulfan Stem Cell Infus... Tacrolimus Methotrexate G-CSF | 5 Years - 75 Years | M.D. Anderson Cancer Center | |
| Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood | NCT00923910 | Leukemia, Acute... Leukemia, Acute... Leukemia, Chron... Myelodysplastic... Non-Hodgkin's L... | WT1 Peptide-Pul... Donor Lymphocyt... IL-4 KLH WT1 Peptides Endotoxin Diphenhydramine Acetaminophen | 1 Year - 74 Years | National Institutes of Health Clinical Center (CC) | |
| Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation | NCT01326728 | Chronic Myeloge... Acute Myelogeno... Acute Lymphobla... Hodgkins Lympho... Non-Hodgkins Ly... | Allogeneic stem... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma | NCT01712490 | Hodgkin Lymphom... | brentuximab ved... doxorubicin bleomycin vinblastine dacarbazine | 18 Years - | Takeda | |
| HD18 for Advanced Stages in Hodgkins Lymphoma | NCT00515554 | Hodgkins Lympho... | Rituximab BEACOPP escalat... | 18 Years - 60 Years | University of Cologne | |
| Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies | NCT00837200 | Non-hodgkins Ly... Hodgkins Lympho... Multiple Myelom... | Oncaspar, Doxil... | 18 Years - | Milton S. Hershey Medical Center | |
| (TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL). | NCT05134740 | Hodgkins Lympho... Non Hodgkins Ly... | TAA-specific CT... | 1 Year - 21 Years | Baylor College of Medicine | |
| Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. | NCT00739141 | Leukemia Myelodysplastic... Non-Hodgkins Ly... Chronic Myeloge... Hodgkins Lympho... | fludarabine, cy... | 18 Years - 70 Years | Memorial Sloan Kettering Cancer Center | |
| A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy | NCT00558675 | Hematological M... Leukemia Lymphoma Multiple Myelom... | AlloStim AlloStim AlloStim AlloStim | 18 Years - | Immunovative Therapies, Ltd. | |
| Biology Studies of Hematologic Cancers | NCT00923442 | Acute Lymphobla... Myelodysplastic... Non-Hodgkins Ly... Acute Myelogeno... Hodgkins Lympho... | 1 Year - 75 Years | National Institutes of Health Clinical Center (CC) | ||
| Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma | NCT01014507 | Hodgkins Lympho... | 8 cycles BEACOP... 8 cycles BEACOP... | 18 Years - 40 Years | University of Cologne |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
